April 25th 2025
The increased risk of depression when oral contraceptives were started following childbirth was "instantaneous," researchers wrote, and was ~50% greater than nonuse.
Clinical Citations: Is anxiety linked with increased asthma symptoms in adolescents?
December 1st 2006Increasing evidence demonstrates that adolescents with asthma are at greater risk for anxiety and depression. However, few studies have investigated the association of psychological disorders with asthma symptoms, an important factor in evaluating asthma treatment. Now the results of a large population-based study of adolescents with asthma confirm that anxiety and depression are highly associated with increased asthma symptoms.
Avoid Paxil in Pregnancy, ACOG Committee Advises
November 30th 2006WASHINGTON -- The antidepressant Paxil (paroxetine) may cause fetal cardiac malformations, and the drug should be avoided if possible in pregnancy, recommended an advisory committee of the American College of Obstetricians and Gynecologists here.
USPSYCH: Antidepressants Benefit Teens Despite Black Box Warnings
November 22nd 2006NEW ORLEANS -- Parents of children and adolescents with depression should be reassured that the benefits of antidepressants outweigh the risks, despite black box warnings about the potential of suicide in adolescents, a pediatric psychiatrist said here.
USPSYCH: Antidepressants May Work More Quickly Than Thought
November 22nd 2006NEW ORLEANS -- Research has challenged the conventional wisdom that depressed patients need three to four weeks to respond to antidepressant medication and that any earlier response is due to the placebo effect, said an investigator here.
Dioxin Alters Development of Male Reproductive System
November 16th 2006DALLAS -- A dioxin in the Vietnam War-era herbicide Agent Orange affects the normal growth of the male reproductive system, according to researchers here. It decreases the risk of benign prostatic hyperplasia and lowers testosterone levels.
Pulmonary Pearls: A 61-year-old woman with insidious onset of dyspnea
November 1st 2006A 61-year-old woman presented with progressive dyspnea of 5 months' duration. She first noticed dyspnea while engaged in her usual daily activities, and it gradually progressed in severity. A primary care physician prescribed bronchodilators without relief. She was subsequently referred for a pulmonary evaluation.
Taking Cardiac Imaging to New Dimensions: Body Surface Mapping
November 1st 2006When your patient presents with chest pain and other symptoms of an acute coronary syndrome (ACS), yet a standard 12-lead ECG shows no evidence of ST-segment elevation myocardial infarction (STEMI), you may face a diagnostic dilemma. The patient could have a non-STEMI ACS for which conservative treatment will suffice--or he could have a STEMI in an electrocardiographically "silent" area and need acute reperfusion therapy.
Taking Cardiac Imaging to New Dimensions: Body Surface Mapping
November 1st 2006When your patient presents with chest pain and other symptoms of an acute coronary syndrome (ACS), yet a standard 12-lead ECG shows no evidence of ST-segment elevation myocardial infarction (STEMI), you may face a diagnostic dilemma.
Parkinson Disease: REFERENCES: EVIDENCE-BASED MEDICINE: RELEVANT GUIDELINES:
October 1st 2006ABSTRACT: Signs that strongly suggest Parkinson disease (PD) include unilateral hand tremor, slowed or decreased movement, and gait changes. Postural alterations include leaning forward or asymmetric shoulder height; the arm may not swing when the patient walks, or it may be held flexed at the elbow. Patients may report increasing difficulties in occupational and social functioning. Mimics of PD include essential tremor, normal pressure hydrocephalus, other neurodegenerative diseases, and drug-induced parkinsonism. Most patients report such nonmotor symptoms as sleep disturbances, visual difficulties, bowel and bladder problems, fatigue, depression, and anxiety. Cognitive impairment in many patients takes the form of slowing of memory and difficulty with visual spatial tasks and executive function. A more realistic treatment goal than tremor eradication is improved overall mobility.
Parkinson Disease: REFERENCES: EVIDENCE-BASED MEDICINE: RELEVANT GUIDELINES:
October 1st 2006ABSTRACT: Although levodopa and the dopamine agonists remain the mainstays of treatment, the number of therapeutic options has increased, and trials of new medications are ongoing. Some trials are evaluating ways to alter disease progression. Medical management of the symptoms of Parkinson disease is generally successful but requires familiarity with the agents to avoid troublesome side effects. Deep brain stimulation surgery is an option for some patients whose symptoms are not adequately managed with medication.